WARSAW — Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, announced the commercial launch of three new hip portfolio offerings, innovatively designed to address a broad range of clinical indications, patient anatomy and surgical techniques.

These enhancements to three successful Zimmer Biomet Hip systems combine clinical heritage with new advances in implant design and musculoskeletal treatment.

The Echo Bi-Metric Microplasty stem is a metaphyseal loading, fit-and-fill femoral prosthesis implanted through a simple, broach-only surgical technique. Based on the clinically proven Bi-Metric family of hip prostheses1, the Echo Bi-Metric Microplasty stem is approximately 30 percent shorter than the full-length Echo Bi-Metric stem, conserving more of the patient’s natural bone and enabling the use of minimally invasive surgical approaches.

The G7 Dual Mobility Construct offers surgeons the benefit of dislocation resistance without the need to constrain the femoral head, combining stability and high range of motion for a variety of patient indications.2,3  The addition of the G7 Dual Mobility Construct expands Zimmer Biomet’s comprehensive portfolio of shell, fixation and bearing options within the G7 Acetabular System, which enable surgeons to personalize implant selection and establish a stable joint in total hip arthroplasty. The G7 Acetabular System also offers clinicians and healthcare systems the benefits of a streamlined instrumentation and delivery platform.

The Arcos One-Piece Femoral Revision system offers three fully porous, titanium stem options with a unique range of sizes that can address small femora. The Arcos One-Piece System builds on the clinical success of the Arcos Modular System4 launched in 2010 and offers the same popular stem geometry, intuitive instrumentation and straightforward surgical technique.

“The Zimmer Biomet hip portfolio is the most comprehensive on the market, and these exciting product introductions represent our strength and commitment to expanding our offerings through our passion and dedication to efficient product development and launch,” said Jim Lancaster, Vice President & General Manager of the global hip business.

“The healthcare environment is rapidly changing, and we remain focused on the timely introduction of clinically relevant, cost-effective solutions that meet the individual needs of patients, surgeons and hospitals around the world.”